Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
More News related to ANP
- Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
- Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
- Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
- Antisense Therapeutics Announces ATL1103 on Track to Move Into Clinical Development
- Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
More News related to ANPI
- Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
- Angiotech Pharmaceuticals (ANPI) Receives FDA Letter Regarding 510k Submission of Bio-Seal
- Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
Third Quarter 2009 Financial Results
VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the third quarter ended September 30, 2009, on Monday November 9, 2009 at 11:00 AM ET (8:00 AM Pacific).
Dial-in information for the earnings call on November 9, 2009 is as
follows:
North America (toll-free): 800.599.9829
International: 617.847.8703
Enter Passcode: 64385781
A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.
A press release announcing Angiotech's financial results will be issued prior to the call on November 9, 2009 at approximately 8:00 AM ET (5:00 AM Pacific).
An archived replay of the call will be available until November 16, 2009.
Replay information is as follows:
North America (toll-free): 888.286.8010
International: 617.801.6888
Enter Passcode: 36157253
Angiotech Pharmaceuticals
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,300 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.
SOURCE Angiotech Pharmaceuticals, Inc.
Related Categories
Press ReleasesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
